ArticleScientific reports2026

Isoliquiritigenin alleviates ulcerative colitis by enhancing the intestinal barrier and improving intestinal microbiota via inhibiting the TLR4/MyD88/NF-κB pathway.

Ruifang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.